Medtronic Adds to Intersect ENT's $30M Series D Round
Medtronic once again joins a $30 million funding round for Intersect Medical and its Propel sinus implants.
All of Intersect's existing "significant" backers participated in the latest round, including Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Medtronic, according to a press release.
Menlo Park, Calif.-based Intersect, which is developing the Propel sinus implant to treat chronic sinusitis, drummed up $30 million in November 2010. Medtronic also participated in that round.